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 In the 1960s, Rosenberg and his colleagues confirmed the anti-cancer activity of 
cisplatin. Although cisplatin was capable of killing testicular cancer cells there were also 
serious side effects. It was necessary to find alternate ways of overcoming side effects, 
and soon many researchers have discovered novel platinum compounds that show similar 
reactivity. Recently, replacing one chloride group to a heterocyclic amine group showed 
significant cytotoxicity with a different binding activity than cisplatin. Previously in our 
lab, [Pt(Me5dien)(NO3)]
+ and [Pt(Et2dien)Cl]
+ have been synthesized and reacted with N-
Acetyl-L-methionine (N-AcMet) and Guanosine 5’-monophosphate (5’-GMP) showed 
unusual reactivity. Unlike most previously studied platinum triamine compounds, 
Me5dien compound was reacting faster with 5’-GMP than N-AcMet, due to the bulkiness 
of the triamine ligand. When both N-AcMet and 5’-GMP were reacted with Et2dien, 5’-
GMP displaced one amine group of the triamine ligand and replaced that spot to form a 
bis-adducts, when the pH was kept below 4. Here a new novel platinum compound has 
been synthesized with a seven-membered chelate ring triamine ligand, Chloro[2-(4-
methyl-1,4-diazepan-1-yl)ethanamine]platinum(II) chloride ([Pt(L)Cl]+). The unusual 
binding activity of [Pt(L)Cl]+ showed a unique pair of products under 1H NMR, 195Pt 





a. Introduction of cisplatin 
In 1960s, Barnett Rosenberg and his colleagues, first discovered the anti-cancer 
activity of platinum compound using various platinum complexes including the very first 
platinum model, cisplatin (Figure 1), synthesized by Michele Peyrone in 1844.1,2 While 
Rosenberg was doing an experiment on electrolysis of platinum mesh electrode in 
Escherichia coli, found as platinum ions were leaching into the ammonia-containing 
medium, there was no cell division in bacteria.1–3 Out of many different platinum 
complexes, cisplatin was the most potent one. In 1978, cisplatin has been acknowledged 
for its cytotoxic activity in testicular cancer cells and then approved by the U.S. FDA for 
medical usage.4 Soon, many analogs of platinum compounds were tested, but only 
carboplatin and oxaliplatin have achieved the approval as a chemotherapy drug in 1979 
and 1994, respectively (Figure 1). So far, cisplatin is one of the most commonly used 
chemotherapeutic drugs. 
 
Figure 1. U.S. FDA approved platinum compounds 
Adapted from reference 9 
b. Mechanism of cisplatin  
The apoptotic mechanism of cisplatin is divided into four main steps.2,3 The first step 
is, the drug enters the cell. The second step is the hydrolysis reaction, in which chloride 
groups are replaced by water molecules.5 The hydrolysis reaction is described below: 
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Pt(𝑁𝐻3)2𝐶𝑙2 +𝐻2𝑂 → [Pt(NH3)2𝐶𝑙(𝐻2𝑂)]
+ + 𝐶𝑙− 
[Pt(NH3)2𝐶𝑙(𝐻2𝑂)]
+ + 𝐻2𝑂 → [Pt(NH3)2(𝐻2𝑂)2]
2+ + 𝐶𝑙− 
Equation 1. Hydration of cisplatin 
The third step is the replacement of water molecules to DNA bases. Then, finally, the 
DNA interaction of cisplatin causes a cytotoxic lesion, and this leads to the induction of 
cellular death by apoptosis through many signal pathways.1,3 
Typically, when platinum starts to interact with either DNA or protein, there are two 
binding activities: monofunctional and bifunctional. Bifunctional activity is the most 
abundant reactivity shown in traditional platinum compounds including cisplatin, 
oxaliplatin, and carboplatin.5 A platinum compound with a bifunctional binding activity 
has two leaving groups that interact with either two DNA bases or amino acids. For 
example, when cisplatin reacts with two N7 of guanine bases, there can be formed two 
guanine adducts: 1,2-d(GpG) or (GpA) intrastrand (Figure 2A) and G-G interstrand 
crosslinks (Figure 2C). Intrastrand crosslink occurs within the same DNA strand with the 
bases adjacent to another. Interstrand crosslink forms covalent bonds across DNA 
strands. On the other hand, a platinum compound with the monofunctional activity only 
replaces one leaving group, and react with either one guanine base (Figure 2B) or one 
amino acid.5,6 The reaction with the protein is similar to the nucleobase, whether 
depending on the type of activity, a platinum compound can bind to either one or two 
amino acids. 
Even though cisplatin and many platinum compounds have shown the anti-cancer 
reactivities, the exact mechanism is still unclear.2 Cancer is itself is not a single defect at 
a single site, but a complex which is can occur at any location of the body. Therefore, 
many types of cancers show different features, and so, despite the finding of cytotoxic 
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platinum compounds is important, it is still required to have a better understanding of 
cancer mechanisms to optimize the best efficacy of the drug. 
 
Figure 1. Different binding types of platinum compound A. Intrastrand cross-link, B. 
Monofunctional, and C. Interstrand cross-link 
Adapted from reference 4. 
c. Side effects of cisplatin 
Although cisplatin and its analogs have the ability to kill cancer cells, they also kill 
normal healthy cells due to cytotoxicity. Platinum is a heavy metal, and therefore it is 
poisonous to the human body specifically.2,7 So, platinum compounds can cause toxic 
effects by interacting multiple signaling pathways and protein while being transported to 
different locations. Those platinum related side effects are severe kidney problems, 
allergic reactions, decreased immunity to infection, gastrointestinal disorders, 
hemorrhage, and hearing loss in some younger patients.  
Another problem arises from the constant usage of platinum complexes. They can 
accumulate within the cell, and this can actually result in one of the drug resistance 
mechanisms.1,2,8 For example, recently, the copper membrane transporter 1 (Ctr1) was 
known to be the main transporter for cisplatin’s cellular uptake.1 Constant usage of 
cisplatin can actually degrade the Ctr1, and therefore the influx of cisplatin is limited, and 
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cause the drug resistance. However, the mechanism of platinum accumulation is still not 
fully understood, so, further study is needed. 
d. Phenanthriplatin 
Due to the side-effects and the possible drug resistance, other novel platinum 
compounds have been tested for their cytotoxic activity. Out of many compounds, 
platinum with monofunctional binding activity has shown significant cytotoxicity with 
various cancer cell lines.6,9,10 Especially, phenanthriplatin, a derivative of pyriplatin [cis-
diamminepyridinechloro-platinum(II)], showed much higher cytotoxic effect than 
cisplatin (Figure 3). 
 
Figure 3. Pyriplatin and Phenanthriplatin 
Adapted from reference 9 
Based on the structure of phenanthriplatin, it replaced one chloride group of cisplatin 
to a heterocyclic amine group and had an extra positive ion.3,11 This extra cation led the 
compound to be hydrophobic and increased the cellular uptake greater than cisplatin.9 
Also, the large amine ligand increased the binding to the DNA base and therefore 
increased the cytotoxic effect more than other compounds. When the mono-adduct is 
formed by the interaction of phenanthriplatin with DNA base, this action induced a slight 




e. Previous research 
Research has shown that platinum with an amine ligand could cause cytotoxicity, 
[Pt(Me5dien)(NO3)]
+ and [Pt(Et2dien)Cl]
+ have been synthesized and tested for their 
reactivity with N-AcMet and 5’-GMP in our lab (Figure 4).12,13  
 
Figure 4. Previously synthesized Me5dien compound and Et2dien compound  
Adapted from reference 12 
Both compounds displayed unusual reactivities; from the Me5dien compound, for the 
first time, 5’-GMP reacted kinetically faster than N-AcMet. Generally, the anti-cancer 
platinum complex prefers to react with the thioether group faster than the nucleobase due 
to the platinum’s high binding affinity of sulfur-containing molecules.9,12 When the 
reaction rate of the Me5dien compound with N-AcMet and 5’-GMP were tested, 5’-GMP 
reacted much faster than N-AcMet.13 This result could be due to the bulkiness of the 
triamine ligand, which caused the steric clashes between the methyl groups of the ligand 
and N-AcMet. A similar activity was observed for pyridine and phenanthriplatin as well, 
the size of phenanthridine’s heterocyclic group is larger than pyridine, so the latter was 
reacting faster with N-AcMet than the previous one.9  
In the case of Et2dien compound, the triamine ligand was somewhat less bulky than 
the Me5dien ligand, so the usual preference of N-AcMet over 5’-GMP was observed. 
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Interestingly, the Et2dien compound showed a unique product formation at a low pH. 
Since this compound was a non-C2 symmetrical compound, multiple mono-adduct 
signals could be observed by the 1H NMR spectroscopy. For example, when the 
compound was reacted with 5’-GMP, rotational isomers were formed. And with N-
AcMet, interestingly, when the pH was kept below 4 for the entire reaction, one 
intermediate resonance was observed, and this converted into a final form over time. 
However, if the pH was kept higher than 4, the intermediate was never observed. 
Furthermore, when both N-AcMet and 5’-GMP were added simultaneously, Et2dien’s 
chelate ring structure opened, and both ligands formed a bond with platinum, which 
produced a ring-opened product. This result could be due to the inter-ligand strain of the 
structure, and to relieve this odd structure, one of the amine groups displaced from the 
platinum, and led two incoming adducts to form a new bond. Also, the unusual activity 
observed along different pH values could be due to the center nitrogen atom, which has 
secondary nitrogen, and its hydrogen can be easily protonated or deprotonated.  
f. My research 
For my research, under the supervision of Dr. Kevin Williams, a novel platinum 
compound has been designed and synthesized using a seven-membered chelate ring 
ligand. We specifically chose this ligand because previously, a triamine ligand with the 
center nitrogen being a secondary atom showed an interesting result like the 
transformation of monofunctional to a bifunctional binding activity or the hindrance of 
the bulkiness on the reaction rate. So, we were interested in how a tertiary center 
nitrogen-containing ligand would react with the DNA nucleobase and the amino acid. 
Then, we chose to use N-AcMet and 5’-GMP to react with. An amino acid with a 
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thioether plays an important role in protein uptake and efflux by being involved in the 
copper transporter 1 (Ctr1). Guanine base was known to be the primary target of platinum 
compounds to cause cytotoxicity. The reactions were checked under 1H and 195Pt NMR 




II. Materials and Methods 
a. Reagents 
Potassium tetrachloroplatinate(II) (K2PtCl4) 2-(4-Methyl-1,4-diazepan-1-yl)ethanamine, 
Guanosine 5’-monophosphate, N-Acetyl-L-methionine, 2-Hydroxy-4-
(methylthio)butyrate, and 9-Ethylguanine are all from Sigma Aldrich. Hydrochloric acid 
(HCl) (concentrated and 1 M) and 99.9% Deuterium Oxide (D2O) are all from Sigma 
Aldrich.  
b. Synthesis of Chloro[2-(4-methyl-1,4-diazepan-1-yl)ethanamine] platinum(II) 
([Pt(L)Cl]+, where L = 2-(4-Methyl-1,4-diazepan-1-yl)ethanamine) 
In a 50 mL round-bottom beaker, 500 mg of Potassium tetrachloroplatinate(II) (K2PtCl4), 
500 mg of 2-(4-Methyl-1,4,-diazepan-1-yl)ethanamine (L) and 20 ml of DI water were 
dissolved. Then, concentrated HCl was added dropwise to approximately pH 4~5. Next, 1 
M HCl was added to adjust pH to around 3~3.5. The solution was stirred and heat-
refluxed for about 6 hours until the color changed from a reddish/orangish color to a 
yellowish color. Once the yellowish color started to appear, the heat/reflux was turned off 
and left it only stirring for overnight. The remaining solution was syringe-filtered. The 
filtered solution was decreased until precipitates were formed by using the rotovap at 
40~50 °C. The solution with precipitates was gravity-filtered and dried overnight. Any 
precipitate in the beaker was washed with ethanol and collected. The filtered compound 
was scraped off from the filtering paper. Finally, the compound was delivered to a 1.5 
mL Eppendorf safe lock tube for storage. Typically, the yield was calculated to be ~40% 
after the synthesis. 
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c. Preparation of [Pt(L)Cl]+ in D2O 
For each experiment, 4.2 mg of [Pt(L)Cl]+ has been prepared with 1 mL of 99.9% D2O in 
a 5 mm NMR tube. 
d. Preparation of interaction of [Pt(L)Cl]+ with Sodium Chloride (NaCl) 
4.2 mg of [Pt(L)Cl]+, 5 mg of NaCl, and 1 mL of D2O have been added to a 5 mm NMR 
tube, and mixed. An additional amount of NaCl was used as there was no change in the 
spectrum observed. 
e. Preparation of interaction of [Pt(L)Cl]+ with N-Acetyl-L-methionine (N-
AcMet) 
4.2 mg of [Pt(L)Cl]+, 1.9 mg of N-AcMet, and 1 mL of D2O have been prepared in a 5 
mm NMR tube. As necessary, an additional amount of N-AcMet was used. 
f.  Preparation of interaction of [Pt(L)Cl]+ with 2-Hydroxy-
4(methylthio)butyrate (But) 
4.2 mg of [Pt(L)Cl]+, 1.6 mg of But, 1 mL of D2O have been prepared in a 5 mm NMR 
tube. An additional amount of But was used in a need. 
g. Preparation of interaction of [Pt(L)Cl]+ with Guanosine 5’-monophosphate 
(5’-GMP) 
4.2 mg of [Pt(L)Cl]+, 4.1 mg of 5’-GMP, and 1 mL of D2O have been prepared in a 5 mm 
NMR tube. 
h. Preparation of interaction of [Pt(L)Cl]+ with 9-Ethylguanine (9-EtG) 
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8.2 mg of 9-EtG was first dissolved in 0.2 mL of dimethyl sulfoxide (DMSO) and then 
added to 4.2 mg of [Pt(L)Cl]+ and 1 mL of D2O in a 5 mm NMR tube. The amount of 9-
EtG was varied as needed. 
i. Preparation of competition of [Pt(L)Cl]+ with N-AcMet and 5’-GMP 
4.2 mg of [Pt(L)Cl]+, 4.1 mg of 5’-GMP, 1.9 mg of N-AcMet, and 1 mL of D2O have 
been prepared in a 5 mm NMR tube. The amount of 5’-GMP and N-AcMet varied as a 
necessity. 
j. pH Adjustment 
In order to increase the pH, both 1% and 10% of Sodium deuteroxide have been used. To 
lower the pH, both 1% and 10% Deuterated nitric acid have been used.  
k. Nuclear Magnetic Resonance (NMR) Spectroscopy 
A JEOL 500 MHz NMR spectrometer has been used to collect the 1H and 195Pt NMR 
data. For each 1H NMR spectrum, a single-pulse experiment was set up for a total of 8 
scans for 1 min. For the 195Pt NMR, the number of scans has been set up differently for 
each experiment as needed. Spectra have been referenced to residual HOD signal (1H) or 
K2PtCl6 (
195Pt). 
l. Mass Spectrometry 
A Varian Liquid Chromatography/ Mass Spectrometry 500 Ion Trap instrument from the 
WKU Center for Research & Development was used for the mass spectrum. Each mass 
spectrum has been set up with 10 µL sample, 500 µL LC/MS graded water, and 500 µL 
LC/MS graded methanol. LC/MS grade methanol was used for the HPLC mobile phase 
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and 50:50 of methanol and 0.1% formic acid was in the solvent. All the spectra were 
collected under the positive mode using an m/z range from 300 to 1200. The samples 





a. Characterization of [Pt(L)Cl]+ 
 
Figure 5. Chemical structure of [Pt(L)Cl]+ 
Chloro[2-(4-Methyl-1,4-diazepan-1-yl)ethanamine]platinum(II) chloride 
(=[Pt(L)Cl]+) showed a pale-yellow color when the synthesis was successful. The 
chemical structure of [Pt(L)Cl]+ shows there are three amine groups with a seven-
membered heterocyclic ring and one chloride group attached to the center platinum 
(Figure 5). Pt, three nitrogens, and the chloride are within the same plane geometry. Since 
the triamine ligand was non-C2 symmetrical with two chiral nitrogens within the seven-
membered ring structure, the compound could generate enantiomers and racemic 






Figure 6. 195Pt NMR spectrum of [Pt(L)Cl]+ 
A fresh sample was set up for a 195Pt NMR with 80,000 scans for a better 
understanding of ligands’ coordination to the platinum. A significant peak was observed 
at approximately -2290 ppm, and this was corresponding to the PtN3Cl (Figure 6). The 
result indicated that [Pt(L)Cl]+ has all three nitrogens of the ligand coordinated.  
Then, approximately 4.2 mg of [Pt(L)Cl]+ has been dissolved in 1.0 mL D2O for 
the solubility check under the 1H NMR. Since the triamine ligand was slightly acidic, the 
pH was around ~3.5 without adjusting. The spectrum showed a singlet at 2.9 ppm, and 
one resonance at 2.7 ppm. Over time, 2.7 ppm peak increased in size (Figure 7), and this 
clued there was a hydrolysis reaction. Thus, the 2.9 ppm was assigned to the CH3 of the 





































































































X : parts per Thousand : 195Pt




Figure 7. [Pt(L)Cl]+ in D2O pH unadjusted 
A fresh sample was analyzed as before except NaCl was added to see whether 
there is any change with those two signals. After 1 hour of adding NaCl, there was just a 
slight change with the 2.7 ppm peak. Then, an excess amount of NaCl has been added 
and checked again after 24 hours (Figure 8). The [Pt(L)(OH)]+ peak was bigger than the 




Figure 8. [Pt(L)Cl]+ with excess NaCl at pH 7 
Another reaction has been set up with an excess amount of HCl to keep the pH of the 
sample below 3. The proton NMR spectrum showed no conversion of 2.9 ppm peak into 
2.7 ppm peak (Figure 9). However, when the same sample’s pH was increased to 10, the 
hydrolysis reaction occurred immediately. Also, no [Pt(L)Cl]+ peak was observed, but 
[Pt(L)OH]+ peak was dominant. When pH was decreased to 4, no chloride related 




Figure 9. [Pt(L)Cl]+ with HCl (pH adjusted) 
b. 1H NMR spectrum of [Pt(L)Cl]+ with N-AcMet in different conditions: ligand 
ratio and pH  
A new sample has been prepared with an equivalent amount of N-AcMet with no 
pH adjustment. Both [Pt(L)Cl]+ and N-AcMet are acidic, the pH is expected to be around 
~3 and 4. The 1H NMR spectrum showed two singlet peaks at 2.0 pm and 2.1 ppm at 20 
min corresponding to unreacted N-AcMet. Also, add to that, a set of [Pt(L)(N-AcMet)]+ 
peaks at 2.05 ppm and 2.4 ppm. After a day, the 2.4 ppm peak kept growing in size, and a 
new peak started to grow at 2.6 ppm. Over time, the initial 2.4 ppm peak converted into 
the 2.6 ppm peak (Figure 10). There was no evidence where the 2.6 ppm peak converted 
back to the 2.4 ppm peak. The same sample was prepared at pH 7. However, unlike at pH 
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4, there was no conversion occurred from the 2.4 ppm peak into the 2.6 ppm peak (Figure 
11). Since pKa of Pt-coordinated water molecules are between ~5.5 and 6.5, this possibly 
slowed the displacement of -OH from the center platinum and led to no formation of 2.6 
ppm peak. 
 
Figure 10. [Pt(L)Cl]+ with N-Acetyl-L-Methionine 1:1 ratio pH unadjusted 
To find out what is causing the initial peak to convert into the other, two different 
experiments were completed. The first sample was with only half the amount of N-
AcMet (Figure 12) and the second sample was prepared with a double amount of N-
AcMet (Figure 13). Since previous experiments reacted faster at pH 4, both samples were 
reacted at pH 4. Those two samples showed similar results within 20 min of dissolving in 
D2O. However, half the amount of N-AcMet has only shown 2.4 ppm peak even after 8 
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days. On the other hand, a double amount of N-AcMet showed a direct formation of a 2.6 
ppm peak within 1 day. When this sample was checked again after 7 days, 2.6 ppm peak 
has grown, but again no other peaks were observed. 
 
Figure 11. [Pt(L)Cl]+ with N-Acetyl-L-Methionine 1:1 ratio pH 7 
The conversion of 2.4 ppm to 2.6 ppm is inevitable, and the amount of unreacted N-
AcMet plays an important role here. Since [Pt(L)Cl]+ has a non-C2-symmetrical ligand, 
when there is mono-adduct formation, the bond between Pt and adduct could rotate, and 








Figure 13. [Pt(L)Cl]+ with N-Acetyl-L-Methionine 1:2 ratio at pH 4 
c. 195Pt NMR spectrum of [Pt(L)Cl]+ with N-AcMet 
To confirm the hypothesis of the N-AcMet reaction is a monofunctional activity, 
a 195Pt NMR spectrometer was done with a fresh sample with a 1:1 ratio of [Pt(L)Cl]+ and 
N-AcMet at pH 4. This sample has been sitting for a long time, and so we have assumed 
that the reaction was done and would have a dominant 2.6 ppm peak. A total of 96,000 
scans have been collected over 12 hours. A significant peak was found at -3300 ppm, 
which is related to the species with the 2.6 ppm peak in the 1H NMR spectrum, with a 
PtN3S (Figure 14). This result established the reaction with N-AcMet forms a mono-
adduct (Figure 15). Since based on the 1H-NMR there are two mono-product peaks at 2.4 
and 2.6 ppm (Figure 10). We wanted to make sure that the 2.4 ppm dominant sample 
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would show a similar result as the 2.6 ppm dominant sample. We have made a fresh 
sample with less amount of N-AcMet to keep the sample would only have 2.4 ppm peak. 
The same 195Pt NMR set-up as previous has been used, and the resulting spectrum 
showed a different significant peak at -3190 ppm than the previous one. This chemical 
shift was corresponding to the PtN2SCl range (Figure 16). This meant, the initial 2.4 peak 
is a chelate ring-opened structure (Figure 17). 
 




Figure 15. PtN3S structure 
 




Figure 17. PtN2SCl structure 
d. Mass spectrum of [Pt(L)Cl]+ with N-AcMet 
In order to prove the reaction with N-AcMet is a monofunctional binding activity, 
a mass spectrum was collected using the liquid chromatography/ mass spectrometry 
instrument. Before we operated the mass spec, we have calculated the mass-to-charge 
ratios of all the possible structures of platinum with N-AcMet and 5’-GMP (Table 1).  
Possible Structures m/z ratio 





[Pt(L)(9-EtG)]+ (ring-opened) 566 




[Pt(L)(5’-GMP)]+ (ring-opened) 750 
[Pt(L)(N-AcMet)(5’-GMP)] 905 
[Pt(L)(5’-GMP)2] 1077 




Figure 18. Mass spectrum of [Pt(L)Cl]+ with N-AcMet at pH 4 
First LC/MS was done with an N-AcMet reaction-finished sample. This sample contained 
both 2.4 and 2.6 ppm peaks in the 1H NMR spectrum. The result showed four significant 
peaks, and two of them were [Pt(L)Cl]+ product peaks (Figure 18). One was 
corresponding to a product where the triamine ring structure is closed, and the other one 
was ring-opened structure according to Table 1. 
 
Figure 19. Mass spectrum of [Pt(L)Cl]+ with concentrated N-AcMet 
Another LC/MS was done and for this time, the sample only had the 2.6 ppm peak 
(Figure 19). Unlike the previous data, the spectrum only showed platinum coordinated to 
one N-AcMet, where the ring structure was still closed. 




LC/MS of N-AcMet 2.6 ppm dominant
















e. 1H NMR spectrum of [Pt(L)Cl]+ with 2-Hydroxy-4(methylthio)butyrate with 
the addition of But over time 
A new sample has been set up with one equivalent ratio of 2-Hydroxy-
4(methylthio)butyrate (But). The structure of But is similar to N-AcMet and therefore we 
expected to see similar product formation patterns unless the N atom of N-AcMet is 
coordinating to the Pt. Unreacted But turned into products within one day. As seen, 
similar 2.4 ppm and 2.6 ppm peaks were observed from 1H NMR as for the N-AcMet. An 
additional amount of But has been added to the same sample and conversion of 2.4 peak 




Figure 20. [Pt(L)Cl]+ with 2-(Hydroxy)-4(methylthio)butyrate 
f. 1H NMR spectrum of [Pt(L)Cl]+ with Guanosine 5’-monophosphate in 




Figure 21. [Pt(L)Cl]+ with Guanosine 5’-monophosphate at pH 4 
When 5’-GMP was reacted with [Pt(L)Cl]+ at pH 4, multiple product signals have 
been observed between 8.0 ppm and 9.0 ppm (Figure 21). Over time, those peaks grew in 
size until there was no unreacted 5’-GMP remaining. At pH 7, product peaks only 
appeared between 8.6 ppm and 9.0 ppm (Figure 22). As mentioned before, [Pt(L)Cl]+ is 
non-C2-symmetrical and has chiral nitrogens. 5’-GMP can form two sets of rotational 
isomers and two sets of enantiomers to be resolved. Therefore, four mono singlets are 
observed. This sample’s temperature has been gradually raised and checked with 1H 
NMR. Four peaks started to coalesce into one broad peak as temperature increased 
(Figure 23). At 60°C, all peaks merged into one, but once the temperature hit 80 °C, the 
peaks started to separate again. This clearly explained the products between 8.6 ppm and 
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9.0 ppm are from two different mono-products which are because [Pt(L)Cl]+ has a 
racemic mixture. 
 
Figure 22. [Pt(L)Cl]+ with Guanosine 5’-monophosphate at pH 7 
When half the amount of 5’-GMP was reacted with [Pt(L)Cl]+ at pH 4, a similar pattern 
was observed as one equivalent amount was reacted. Again, multiple products peak 









Figure 24. [Pt(L)Cl]+ with half amt. of Guanosine 5’-monophosphate at pH 4 
g. Mass spectrum of [Pt(L)Cl]+ with 5’-GMP 
Since the reaction with 5’-GMP showed multiple peaks at pH 4 under the 1H NMR 
spectrum, a sample in which the reaction was started at pH 4 has been used for the 
LC/MS to verify the characteristics of the peaks. According to the mass spectrum, there 
were two significant peaks from 5’-GMP related products. One peak matched with 
platinum coordinated to one 5’-GMP, and the other one corresponded to two 5’-GMPs 




Figure 25. Mass spectrum of [Pt(L)Cl]+ with 5’-GMP at pH 4 
h. 1H NMR spectrum of [Pt(L)Cl]+ with 9-EtG in different conditions: ligand 
ratio, pH, and temperature 
9-Ethylguanine was used to understand the reaction of [Pt(L)Cl]+ with 5’-GMP 
better. At the beginning of the experiment, 9-EtG was not soluble in water We used 200 
μL of dimethyl sulfoxide (DMSO) to dissolve it first, then added to D2O with no pH 
adjustment. 9-EtG was acidic, the sample’s pH was expected to be around ~4 and 5. 
Within 20 min of the reaction, only unreacted 9-EtG was observed under the 1H NMR 
(Figure 26). After 24 hours, [Pt(L)(9-EtG)]+ resonance was detected and over time, 
multiple peaks developed. Interestingly, two singlets at 8.2 and 8.8 ppm, started to 
decrease, and the broad peak at 8.45 ppm increased (Figure 26). When a fresh sample 
was made at pH 7, the reaction rate was much faster than there was no pH adjustment. 
Within 6 days of the reaction, two singlets at 8.2 and 8.8 ppm disappeared, only a broad 
resonance was observed at 8.4 ppm (Figure 27). In addition to that, the pH shift of 
unreacted 9-EtG was large, the sample’s pH had to be adjusted to 7 every day.  
LC/MS of 5’-GMP at pH 4

















Figure 28. [Pt(L)Cl]+ with half amt. of 9-Ethylguanine with no pH adjustment 
To better understand whether the reaction rate was affected by the concentration of 
unreacted 9-EtG or the pH, another sample was prepared with 0.5 equimolar of 9-EtG at 
pH 4. Again, the conversion of two initial singlets to the broad resonance was observed 
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over time (Figure 28). However, even after 21 days of the reaction, peaks at 8.2 and 8.8 
ppm remained in a good size. The reaction rate could be affected by the pH possibly. 
i. 1H NMR spectrum of [Pt(L)Cl]+ with 5’-GMP and N-AcMet in different 
conditions: ligand ratio, pH, and temperature 
Both N-AcMet and 5’-GMP have been added to [Pt(L)Cl]+ at pH 4 
simultaneously (Figure 29). Within 20 min, Pt-N-AcMet coordinated resonance was 
observed at 2.05 ppm and 2.4 ppm, however, 5’-GMP did not have any reaction. After 3 
days, multiple 5’-GMP resonances were shown between 8.0 ppm and 9.0 ppm. 
Interestingly, 2.05 ppm N-AcMet signal has decreased as [Pt(L)(5’-GMP)]+ formation. 
This pattern tended to continue over time and evidenced that N-AcMet is being replaced 
by 5’-GMP. Also, since not all N-AcMet products were replaced, another possibility is 




Figure 29. [Pt(L)Cl]+ with 5’-GMP and N-AcMet at pH 4 
Another competition was observed set up at pH 7 (Figure 30) under the 1H NMR. Unlike 
the fast formation of 5’-GMP product, noticeable resonance showed only after 18 days. 
As mentioned before, at pH 7, water molecules were deprotonated and therefore the 
reaction rate was very slow. Although coordination of [Pt(L)Cl]+ with 5’-GMP was slow, 
similar replacement activity was observed. Based on the results, when there is 
competition, N-AcMet reacts faster than 5’-GMP, but the latter one slowly replaced the 
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initial product, and add to that, both DNA nucleobase and amino acid can attach to 
platinum. 
 
Figure 30. [Pt(L)Cl]+ with 5’-GMP and N-AcMet at pH 7 
A competition reaction was done with a 1:1:1 ratio of [Pt(L)Cl]+, N-AcMet, and 5’-GMP 




Figure 31. [Pt(L)Cl]+ with both double amount of 5’-GMP and N-AcMet at pH 4 
j. Mass spectrum of competition of 5’-GMP and N-AcMet with [Pt(L)Cl]+ 
An LC/MS spectrum was obtained from a reaction-finished competition sample at 
pH 4. According to the result, there were three peaks from newly coordinated products: 
one with single N-AcMet, one with single 5’-GMP, and one with both N-AcMet and 5’-




Figure 32. Mass spectrum of competition reaction at pH 4 
The mass spec has shown [Pt(L)Cl]+ could actually have both monofunctional and 
bifunctional reactivity under certain circumstances. 
 
LC/MS of competition at pH 4













Since Rosenburg’s finding on the anti-cancer platinum compound, much research 
has been conducted. Recently, replacing one of the chloride group to a heterocyclic 
amine group has shown significant cytotoxicity. Phenanthriplatin was recognized to be 
the platinum compound with higher cytotoxicity, and also the hydrophobic amine ligand 
would transport to the target site better than cisplatin. Typically, cisplatin would bind to 
two DNA bases through either 1,2-d(GpG)/(GpA) intrastrand or GpG interstrand, and 
make a lesion which induces multiple signaling pathways to generate cellular death, and 
on the other hand, phenanthriplatin would distort the DNA helix with the large amine 
ligands, and inhibit the transcription.5,9,14 
Though the exact mechanism of how a platinum compound is being uptaken into 
the cell and the source of the drug resistance is unclear, it is important to continue to test 
various platinum derivatives. It has been proven the reaction with sulfur-containing 
amino acids, like in metallothionein, plays an important role in the cellular uptake, and 
efflux of the drug by being a key part of the copper transporter 1.9,12 However, the ability 
of cisplatin to degrade Ctr1, it can also play a role in the drug resistance.  
Generally, platinum compounds favor binding to sulfur-containing protein than 
nucleobases due to its high binding affinity. On some occasions, this reactivity could be 
reversed when there is a strong inter-ligand strain or the bulkiness of amine ligand.9,13 
Here, a newly synthesized novel platinum compound, [Pt(L)Cl]+ has a pale-
yellow color. Almost immediately dissolving [Pt(L)Cl]+ into water started the hydrolysis 
reaction (Figure 7), and a 1H NMR spectrum was gathered to check its solubility. The 
replacement of the chloride to the hydroxide was expectable but this was highly 
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dependent on pH values. When the pH was kept low with HCl, no hydrolysis reaction 
was observed, but the same sample’s pH got increased to 10, there was an instant 
replacement, which was irreversible. After the hydroxide resonance was observed from 
the 1H NMR spectrum, we have added an excessive amount of NaCl, but there was no 
change. To have a better understanding of the platinum to the ligand coordination, a 195Pt 
NMR was generated. From the 195Pt NMR spectrum, a significant peak was found at 
around -2300 ppm. According to Oehlsen et al., this range was corresponding to PtN3Cl, 
which means three nitrogens of the triamine ligand are attached to the center platinum.15  
Platinum compounds’ reaction with the protein is important and closely related to 
the cellular uptake and efflux. In this experiment, N-AcMet was used because it is a key 
structure of Ctr1. The reaction produced two different mono resonances within one day 
(Figure 10). Interestingly, the initial peak merged into the latter one that appeared over 
time. So, our first guess assumed that the initial peak is a less stable mono-product, which 
turns into a final stable mono-product, as observed with the Et2dien compound, as time 
passed. In the case of Et2dien compound, it would form an initial less-stable product 
when the pH was below 4, and replaced by the final stable product. However, if the pH 
was kept above 4, there was no initial product’s peak occurring, but the final product was 
directly formed.12 
Like the Et2dien compound, [Pt(L)Cl]
+ is a non-C2 symmetrical compound, with 
two chiral carbons, and the N-AcMet structure has one chiral sulfur. Once they start to 
react, there are two improper torsion angles of the hydrogen on the triamine ligand. 
Depending on the position of the methyl group attached to the sulfur, syn- and anti-
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conformations are possible. Therefore, a total of 8 different R, S combinations with being 
syn or anti enantiomers were possible (Table 2).12 
Chirality at both N Chirality at S Torsion 
R R Syn 
R R Anti 
R S Syn 
R S Anti 
S R Syn 
S R Anti 
S S Syn 
S S Anti 
Table 2. Possible enantiomers of [Pt(L)Cl]+ with N-AcMet 
Initially, we believed that the chloride or the hydroxide is replaced by one of 8 
possible enantiomers to form a mono-product (Figure 15). Then slowly, unreacted N-
AcMet reacts with [Pt(L)Cl]+ and knocks off the initial mono-product and forming the 
final stabilized mono-product. 
Unlike the pH condition of the Et2dien compound, the reaction rate of [Pt(L)Cl]
+ 
with N-AcMet could be manipulated by the amount of unreacted N-AcMet presence in 
the sample. In low [unreacted N-AcMet], the conversion of the initial peak to the final 
peak was extremely slow even after 8 days (Figure 12). However, with excess N-AcMet 
presence, the final product was dominant within one day (Figure 13). To support the idea 
of reaction rate relationship to the concentration, we used 2-hydroxy-4-
(methylthio)butyrate, which was the analog of a methionine (Figure 20).12 We started the 
reaction with 1:1 ratio of [Pt(L)Cl]+ and within one day, we observed the formation of 
both less stable and final stable products. Over time, we added an excess amount of But, 
and a less stable peak decreased in size, and the final product’s peak increased. 
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Our initial idea was incorrect after obtaining the result of the LC/MS. The mass 
spectrometer showed two peaks which were coordinating to the mono-N-AcMet product, 
and one was ring-opened and the other one was the ring-closed structure of N-AcMet 
(Figure 18). The ring-opened structure could be possible due to the bulkiness of the 
amine ligand. Since there were two mono-peaks from the 1H NMR, we wanted to identify 
which peak was corresponding to which one of two structures. We generated two sets of 
195Pt NMR with one having the less-stable 2.4 ppm peak dominant, and the other one 
having the final 2.6 ppm peak dominant. As we thought, the sample with the less-stable 
product showed a significant peak at around -2190 ppm, and this was corresponding to 
PtN2SCl. The sample with the final product showed a peak at around -2300 ppm, and this 
was from PtN3S. Based on the mass spec and the 
195Pt NMR, once N-AcMet starts to 
interact with [Pt(L)Cl]+, one nitrogen would displace, and replaced by N-AcMet. Next, 
unreacted N-AcMet would interact with [Pt(L)Cl]+ and form the final stable product, 
where the triamine group is coordinated to the platinum with either the chloride or the 
hydroxide displaced by N-AcMet (Figure 33). 
 
Figure 33. Reaction scheme of [Pt(L)Cl]+with N-AcMet 
time
initial 2.4 ppm product
[Pt(L)Cl]+
final 2.6 ppm product
+ N-AcMet
final 2.6 ppm product
+ N-AcMet (double amount)
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Based on the LC/MS spectrum, 1H NMR and 195Pt NMR, we conclude the 
reaction with N-AcMet is producing a monofunctional binding activity and also, 
depending on the amount of unreacted N-AcMet presence in the sample, the reaction rate 
could change. 
As mentioned before, there are two binding activities of the platinum compound 
with DNA: monofunctional and bifunctional. Cisplatin typically showed a bifunctional 
activity.1,2,9 Once cisplatin starts to react with nucleobases, it can form two types of 
different covalent cross-links. The first type is GpG or GpA intrastrand cross-link. This 
happens within the same DNA strand. The second type is GpG interstrand cross-link, 
which happens between two adjacent DNA strands.5 On the other hand, phenanthriplatin 
and pyriplatin bind to DNA monofunctional, and here they only react with the guanine 
basex.9 
The reaction of [Pt(L)Cl]+ with 5’-GMP showed a unique product formation 
pattern. At pH 4, within one day, multiple product resonances were observed under the 
1H NMR. Over time, all the peaks increased in size until there was no unreacted 5’-GMP 
remaining. At pH 7, and [Pt(L)(5’-GMP)]+ resonances were found between 8.6 ppm and 
8.8 ppm. We hypothesized fewer product signals would occur due to the slow reaction 
rate at pH 7. The pKa of a platinum compound with -OH group is between 5.5 and 6.5, so 
the solution is deprotonated and due to the hydrolysis reaction, so there are more 
[Pt(L)OH]+ than [[Pt(L)Cl]+.12 Since, two similar-sized peaks were observed at pH 4 
these could linked to two sets of rotational isomers and their mirror images. To confirm 
this idea, we have increased the pH 7 sample’s temperature and gathered the 1H NMR 
spectra (Figure 23). At the room temperature, the interconversion of four peaks was slow, 
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the peaks were clearly distributed. However, at 40°C, the peaks started to coalesce, and at 
60°C, all the peaks sharpened into one. A similar result was seen in the Et2dien 
compound, which also has a non-C2 symmetrical ligand. To identify those multiple 
product peaks of [Pt(L)(5’-GMP)]+ at pH 4, we examined the LC/MS spectrometry. 
Interestingly, two significant peaks were observed; one corresponding to a mono-adduct 
of 5’-GMP, and the other one to bis-adduct of 5’-GMP, which in this case could happen 
by displacing one of the amine groups. The ring-opening pattern was observed in Marzilli 
group’s compound ([Pt(di-(6-methyl-2-picolyl)amine)Cl]Cl) as well.16  
 
Figure 34. Unusual chelate ring-opening of a platinum compound 
Adapted from reference 16. 
The ring-opening was possible due to the methyl group of the triamine ligand causing a 
steric hindrance, which led one of the amine group to displace (Figure 34).16 Since, 
[Pt(L)Cl]+ has a bulky ligand at the side with the seven-membered ring, when there is a 
second 5’-GMP, one of the amine groups could dissociate, and would be replaced by 5’-
GMP. However, no formation of bis-adduct was observed at pH 7, and this is still 
unclear. In order to support the reaction with 5’-GMP, we did another experiment with 9-
Ethylguanine, which did not have the phosphate group or the chiral center, so it could 
only product rotational isomers. Unlike 5’-GMP, preparing a sample with 9-EtG required 
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additional steps. Dimethyl sulfoxide (DMSO) was used to dissolve unreacted 9-EtG 
firstly, and then it was added to [Pt(L)Cl]+ and D2O. For this sample particularly, the pH 
shift was big with the unreacted 9-EtG peak in the 1H NMR, the sample’s pH had to be 
adjusted every time before running the NMR spectrometer. Within one day of the 
reaction, two distinct singlets at 8.15 ppm and 8.8 ppm were observed under the spectra 
(Figures 26, 27, and 28). Over time, these peaks converted into a broad peak at 8.4 ppm. 
Referencing Marzilli group’s 1H NMR result, this conversion is the transformation of 
mono-product to bis-product.16 Both 9-EtG and 5’-GMP reactions’ rate was highly 
dependent on the pH, but unlike 5’-GMP, the conversion of mono- into bis-product was 
inevitable whether there are more or less [unreacted 9-EtG]. 
 
Figure 35. Reaction scheme of [Pt(L)Cl]+ with 5’-GMP 
Although the conversion of mono 5’-GMP into bis 5’-GMP is still unclear when the 
reaction starts at pH 4, there are evenly distributed structures of platinum with chloride or 
hydroxide, so both mono- and bis-products are possible. However, at pH 7, due to the 






+ 5'-GMP @ pH4
+ 5'-GMP @ pH7
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formation (Figure 35). Unlike the reaction with N-AcMet, the concentration of 5’-GMP 
did not affect the reaction rate (Figure 24).  
Competition reaction of [Pt(L)Cl]+ with both N-AcMet and 5’-GMP is important 
because due to the platinum compound’s soft ligand preference, N-AcMet forms faster 
than 5’-GMP.9,12 However, reaction with N-AcMet could be slowed depending on the 
bulkiness of the amine ligand. Previously, the Me5dien compound reacted faster with 5’-
GMP than N-AcMet, and phenanthriplatin favored reaction with 5’-GMP over N-AcMet 
as well.9,13 When a competition was started at pH 4 with an equimolar amount of N-
AcMet and 5’-GMP, [Pt(L)Cl]+ favored to bind to N-AcMet faster than 5’-GMP (Figure 
29). It took at least three days to react with 5’-GMP, and once the guanine related 
resonances began to appear, methionine peaks started to decrease in size and evidenced 
there is a replacement. Despite the conversion was observed, even after 9 days of 
reaction, there were still N-AcMet coordinated products remaining. We hypothesized 
there are both N-AcMet and 5’-GMP coordinated to platinum like the Et2dien compound. 
Based on the 1H NMR of the competition reaction at pH 7, there was the immediate 
formation of [Pt(L)(N-AcMet)]+ products, but unlike at pH 4, it took at least 18 days for 
5’-GMP to form products. As seen in 5’-GMP reaction, since the competition was 
generated at pH 7, only mono-products of 5’-GMP were formed. However, the 
replacement of [Pt(L)(N-AcMet)]+ to [Pt(L)(5’-GMP)]+ happened as same as at pH 4. 
According to the LC/MS spectrum of competition reaction at pH 4, there were multiple 
peaks found. As we expected, [Pt(L)(N-AcMet)]+ and [Pt(L)(5’-GMP)]+ was detected, 
and add to that [Pt(L)(N-AcMet)(5’-GMP)] peak was also detected. One possible 
hypothesis is, once the competition begins, kinetically favored N-AcMet would dissociate 
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one of the triamine group and take the spot. Over time, thermodynamically favored 5’-
GMP would displace either the chloride group or the hydroxide group to form a bis-
product. As the reaction with 5’-GMP is still unclear, we presume there are two possible 
ways of product formation depending on the starting pH value (Figure 36&37). 
 
Figure 36. Reaction scheme of competition at pH 4 
 
Figure 37. Reaction scheme of competition at pH 7 
A novel platinum compound, [Pt(L)Cl]+, was synthesized successfully and reacted 
with N-AcMet and 5’-GMP. Like other typical platinum compounds, [Pt(L)Cl]+ preferred 
to bind to the amino acid kinetically faster, but over time, the guanine base replaced N-
AcMet and formed stable product thermodynamically. Besides, the reactions with each of 
N-AcMet and 5’-GMP showed unusual activity. There were two forms of [Pt(L)(N-
AcMet)+ products with one being ring-opened and the other one is ring-closed. Both 
[Pt(L)(5’-GMP)]+ and [Pt(L)(5’-GMP)2] were observed when the reaction was generated 
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at pH 4, but at pH 7, only mono-product was produced, and there was evidence of bis-
product formation. 
 [Pt(L)Cl]+’s future work would require two additional experiments. The first one 
will be the study of molecular mechanics. Since rotational isomers and enantiomers were 
possible, we still need to get the optimized structure with the minimum formation energy. 
Also, this will help us to understand the dissociation of the chelate ring better, as well. 
The second one is the biological study of [Pt(L)Cl]+ with different cancer cells. This 
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